Lanreotide Acetate Injection
Product Images NDC 76282-718

Product Visual Gallery

This gallery contains 36 technical images submitted to the FDA as part of the official labeling for Lanreotide Acetate (NDC 76282-718). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lanreotide 120 mg Carton Label (Lanreotide 120 mg Carton Label)

This is a description is for Lanreotide Injection, a medication that comes in a concentration of 120 mg per 0.5 mL. The storage instructions recommend refrigeration at 2-8°C (36-46°F) in the original packaging. The usual dosage should be determined by a healthcare provider. Each syringe contains a lanreotide acetate solution corresponding to 120 mg of lanreotide per syringe. For further information or inquiries regarding Lanreotide Injection, contact the manufacturer at the provided hotline number.*

FDA Label Image

Lanreotide 120 mg Pouch Label (Lanreotide 120 mg Pouch Label)

FDA Label Image

Lanreotide 60 mg Pouch Label (Lanreotide 60 mg Pouch Label)

This is a description of Lanreotide Injection, a medication with a strength of 60 mg/0.2 ml for deep subcutaneous administration. It is important to note that it should be administered by a healthcare professional. The user is advised to call 1-866-604-3268 for training on how to perform a practice injection. It is recommended to read both sides of the yellow instructions for use and prescribing information thoroughly. The medication should be stored refrigerated at 2°C-8°C (36°F - 46°F) in its original package and protected from light. Additionally, it is crucial to keep the device out of reach of children. Issued in September 2022.*

FDA Label Image

Lanreotide 60mg Carton Label (Lanreotide 60mg Carton Label)

FDA Label Image

Lanreotide 90mg Carton Label (Lanreotide 90mg Carton Label)

Description: This is information about Lanreotide Injection 90 mg/0.3 mL. It includes details such as storage temperature requirements, manufacturer information, usage instructions, and a contact number for inquiries. The text indicates that the product should be stored between 36°F - 46°F in its original package and provides dosage information. Additionally, it mentions the manufacturer as Pharmathen International, S.A. based in Rodopi, Greece. For any questions about Lanreotide Injection, the provided contact number can be used.*

FDA Label Image

Lanreotide 90mg Pouch Label (Lanreotide 90mg Pouch Label)

This is a description of Lanreotide Injection, which is a medication administered by healthcare professionals. The injection is meant for deep subcutaneous administration and should be stored refrigerated at 2-8°C. It is crucial to read both sides of the instructions and prescribing information for proper use. For any inquiries or assistance, contact Lanreotide Cal at 1-866-604-3268.*

FDA Label Image

Lanreotide Fig 1 (Lanreotide Fig 1)

Not available.*

FDA Label Image

Lanreotide Fig 10 (Lanreotide Fig 10)

FDA Label Image

Lanreotide Fig 11 (Lanreotide Fig 11)

FDA Label Image

Lanreotide Fig 12 (Lanreotide Fig 12)

FDA Label Image

Lanreotide Fig 13 (Lanreotide Fig 13)

FDA Label Image

Lanreotide Fig 14 (Lanreotide Fig 14)

FDA Label Image

Lanreotide Fig 15 (Lanreotide Fig 15)

FDA Label Image

Lanreotide Fig 16 (Lanreotide Fig 16)

FDA Label Image

Lanreotide Fig 17 (Lanreotide Fig 17)

FDA Label Image

Lanreotide Fig 18 (Lanreotide Fig 18)

FDA Label Image

Lanreotide Fig 19 (Lanreotide Fig 19)

FDA Label Image

Lanreotide Fig 2 (Lanreotide Fig 2)

FDA Label Image

Lanreotide Fig 20 (Lanreotide Fig 20)

FDA Label Image

Lanreotide Fig 21 (Lanreotide Fig 21)

FDA Label Image

Lanreotide Fig 22 (Lanreotide Fig 22)

FDA Label Image

Lanreotide Fig 23 (Lanreotide Fig 23)

FDA Label Image

Lanreotide Fig 3 (Lanreotide Fig 3)

FDA Label Image

Lanreotide Fig 4 (Lanreotide Fig 4)

FDA Label Image

Lanreotide Fig 5 (Lanreotide Fig 5)

FDA Label Image

Lanreotide Fig 7 (Lanreotide Fig 7)

FDA Label Image

Lanreotide Fig 8 (Lanreotide Fig 8)

This appears to be a description of a pre-filled syringe kit containing a needle cap, tray, and expiration date/dose label. The kit is likely used for medical purposes or medication administration.*

FDA Label Image

Lanreotide Fig 9 (Lanreotide Fig 9)

FDA Label Image

Lanreotide Pouch Stick 120 mg (Lanreotide Pouch Stick 120 mg)

This text provides details about the artwork for a pouch stick named LANREO 120MG manufactured by Pharmathen. The dimensions of the pouch stick are 77x38mm, the code is 2834919, and the date is 27/10/2023. The artwork was checked by Grigoris Kalivas and the software used was Adobe Illustrator CS6. The contact name for customer service is Panagiotis Papanikolopoulos, who is the Artworks Supervisor. Special instructions may follow these details.*

FDA Label Image

Lanreotide Pouch Stick 60 mg (Lanreotide Pouch Stick 60 mg)

This text provides information about the artwork for a pouch stick product by Pharmathen. The document includes the dimensions (77x38mm), code (2834917), date (27/10/2023), and details about the printing and materials used. It also mentions the graphic check done by Grigoris Kalivas using Adobe Illustrator CS6. The contact name for customer service is Panagiotis Papanikolopoulos, who is the Artworks Supervisor. Special instructions may be detailed further in the text.*

FDA Label Image

Lanreotide Pouch Stick 90 mg (Lanreotide Pouch Stick 90 mg)

This text provides details on an artwork named "POUCH STICK LANRED SOMGLAJANDAGIPLA US EL" from Pharmathen, with dimensions of 77x38mm. The code is 2834918, and the date is 27/10/2023. The artwork is being checked by Grigoris Kalivas using Adobe Illustrator CS6. The contact person is Panagiotis Papanikolopoulos from Customer Service. Special instructions are mentioned in the document.*

FDA Label Image

Lanreotide Structure (Lanreotide Structure)

This text is a chemical formula that describes a specific sequence of amino acids. The sequence is as follows: D-BNal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 x (CH3COOH), where x can range from 1.0 to 2.0.*

FDA Label Image

Lanreotide Syringe 60mg (Lanreotide Syringe 60mg)

This is information related to an artwork for a pharmaceutical product named "Syring Lanreanda Gomg Laiexelaciplus". The artwork was created using Adobe Illustrator CS6 with dimensions of 70x15mm. The contact name is Panagiotis Papanikolopoulos, and the date of creation was 20/10/2023. The graphic check was done by Grigoris Kalivas.*

FDA Label Image

Lanreotide Syringe 120 mg (Lanreotide Syringe 120 mg)

FDA Label Image

Lanreotide Syringe 90 mg (Lanreotide Syringe 90 mg)

FDA Label Image

Lanreotide Fig 6 (Lanreotide Fig 6)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.